Breast Cancer Clinical Trial

Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History

Summary

In this study,the investigators are looking to see how older women who are survivors of breast cancer and either did or did not receive chemotherapy are affected by treatment, compared to older women who have never had cancer. Thinking and memory abilities normally decrease with age and the investigators want to see if the long-term effects of cancer treatments may make these problems worse. The investigators will also look at how thinking and memory abilities of older women are affected by genetics and smoking history. Genetics and other factors may affect the brain's chemicals or structure, and may either protect against the negative effects on thinking or make someone more at risk for them.

MSK participants who previously consented to allostatic blood and saliva collection but have not yet provided any allostatic blood or saliva samples for this study, will not be asked to provide any further samples at follow-up. Participants who have consented to allostatic sample collection and provided one set of allostatic blood and saliva samples at a previous follow-up study visit will still be asked to provide a second set of samples at a later follow-up. COH participants will continue to provide allostatic blood and saliva collection as originally outlined

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

The neuropsychological assessments were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the tests. Friend nominated, non-cancer controls will be frequency matched on age (+/- 5 years), education (less than college vs. some college and above), and race will be recruited using the same eligibility criteria as survivors except for no history of cancer.

For cancer patients, eligibility includes:

As per medical record or self-report, post-menopausal female
As per medical record or self-report, age 60 or older at recruitment
As per medical record or self-report, age 55 or older at the time of breast cancer diagnosis

As per medical record or self report, for cancers other than breast cancer or non-melanoma/basal cell skin cancer/squamous cell skin cancer:

Patient must be at least 3 years post diagnosis of that cancer
Not received chemotherapy treatment or external beam radiation for that cancer
As per medical record or self-report, 5-15 years post diagnosis of breast cancer at the time of enrollment
As per medical record or self-report, no evidence of any cancer disease
American Joint Committee on Cancer (AJCC) stages 0-III breast cancer survivor as per clinical judgment/electronic medical record (EMR)
Score of < 11 on the Blessed Orientation-Memory-Concentration Test (BOMC)

In the judgment of the consenting professional, able to communicate well enough in English through verbal and written communication to complete the study assessments and provide informed consent

English proficiency verified through an adapted Bidimensional acculturation scale, score of 2.5 or above ***The scale will only be administered to participants who report also speaking a language other than English.

For controls participants, eligibility includes:

As per medical record or self-report, post-menopausal female
As per medical record or self-report, age 60 and older at recruitment

In the judgment of the consenting professional, able to communicate well enough in English through verbal and written communication to complete the study assessments and provide informed consent

°English proficiency verified through an adapted Bidimensional acculturation scale, score of 2.5 or above. ***The scale will only be administered to participants who report also speaking a language other than English.

Score of < 11 on the Blessed Orientation-Memory-Concentration Test (BOMC)
As per self report, no history of treatment with chemotherapy
As per self report no history of cancer except non-melanoma/basal cell skin cancer squamous cell skin carcinoma

Exclusion Criteria:

For cancer patients, exclusion criteria includes:

As per medical record or self report, diagnosis of neurodegenerative disorder that affects cognitive function (e.g., Alzheimer's, Parkinson's, Multiple Sclerosis, dementia, seizure disorders, etc)
As per medical record or self report, history of stroke or head injury requiring visit to the emergency room or hospitalization
As per medical record or self report, diagnosis of major Axis I psychiatric disorder including schizophrenia, manic-depressive disorder, or substance use disorders
As per self report or in the judgment of the consenting professional, visual or auditory impairment that would preclude ability to complete assessments
As per self report or as confirmed by the medical record, if the patient is taking anti-depression or anti-anxiety medication, < 2 months on these medication or a change in the prescribed dose in the past 2 months
Previously or actively participating in protocol MSK IRB# 10-079

For control participants, exclusion criteria include

As per self report, diagnosis of neurodegenerative disorder that affects cognitive function (e.g., Alzheimer's, Parkinson's, Multiple Sclerosis, dementia, seizure disorders, etc.)
As per self report, history of stroke or head injury requiring visit to the emergency room or hospitalization
As per self report, diagnosis of major Axis I psychiatric disorder including schizophrenia, manic-depressive disorder, or substance use disorder
As per self report, or in the judgment of the consenting professional, visual or auditory impairment that would preclude ability to complete assessments
As per self report,if the person is taking anti-anxiety or anit-depression medication <2 months on these medications or a change in the prescribed dose past 2 months
Previously or actively participating in protocol 10-079

Study is for people with:

Breast Cancer

Estimated Enrollment:

499

Study ID:

NCT02122107

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

City of Hope
Duarte California, 91010, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10021, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

499

Study ID:

NCT02122107

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.